Cargando…
Development of pharmacotherapies for abdominal aortic aneurysms
The cardiovascular field is still searching for a treatment for abdominal aortic aneurysms (AAA). This inflammatory disease often goes undiagnosed until a late stage and associated rupture has a high mortality rate. No pharmacological treatment options are available. Three hallmark factors of AAA pa...
Autores principales: | Weaver, Lauren M., Loftin, Charles D., Zhan, Chang-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514980/ https://www.ncbi.nlm.nih.gov/pubmed/35780618 http://dx.doi.org/10.1016/j.biopha.2022.113340 |
Ejemplares similares
-
Recent Advances in Pharmacotherapy Development for Abdominal Aortic Aneurysm
por: Yoshimura, Koichi, et al.
Publicado: (2012) -
Cyclooxygenase-2 Inhibition Attenuates Abdominal Aortic Aneurysm Progression in Hyperlipidemic Mice
por: Ghoshal, Sarbani, et al.
Publicado: (2012) -
Pharmacotherapies and Aortic Heme Oxygenase-1 Expression in Patients with Abdominal Aortic Aneurysm
por: Hofmann, Anja, et al.
Publicado: (2022) -
Pharmacotherapy in Clinical Trials for Abdominal Aortic Aneurysms: A
Systematic Review and Meta-Analysis
por: Su, Zhixiang, et al.
Publicado: (2022) -
The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis
por: Guessous, Idris, et al.
Publicado: (2008)